RG
AMED
Renaissance Group’s Amedisys AMED Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-8,538
| Closed | -$713K | – | 272 |
|
2022
Q4 | $713K | Sell |
8,538
-190
| -2% | -$15.9K | 0.04% | 218 |
|
2022
Q3 | $845K | Buy |
8,728
+285
| +3% | +$27.6K | 0.05% | 208 |
|
2022
Q2 | $888K | Buy |
8,443
+421
| +5% | +$44.3K | 0.05% | 205 |
|
2022
Q1 | $1.38M | Buy |
8,022
+390
| +5% | +$67.2K | 0.06% | 141 |
|
2021
Q4 | $1.24M | Buy |
7,632
+332
| +5% | +$53.7K | 0.05% | 155 |
|
2021
Q3 | $1.09M | Buy |
7,300
+3,106
| +74% | +$463K | 0.05% | 160 |
|
2021
Q2 | $1.03M | Buy |
4,194
+439
| +12% | +$108K | 0.04% | 166 |
|
2021
Q1 | $994K | Buy |
3,755
+180
| +5% | +$47.6K | 0.04% | 166 |
|
2020
Q4 | $1.05M | Buy |
3,575
+17
| +0.5% | +$4.99K | 0.05% | 139 |
|
2020
Q3 | $841K | Sell |
3,558
-1,010
| -22% | -$239K | 0.04% | 135 |
|
2020
Q2 | $907K | Sell |
4,568
-42
| -0.9% | -$8.34K | 0.04% | 133 |
|
2020
Q1 | $846K | Buy |
4,610
+254
| +6% | +$46.6K | 0.05% | 119 |
|
2019
Q4 | $727K | Buy |
4,356
+378
| +10% | +$63.1K | 0.03% | 194 |
|
2019
Q3 | $521K | Buy |
3,978
+41
| +1% | +$5.37K | 0.02% | 192 |
|
2019
Q2 | $478K | Buy |
3,937
+40
| +1% | +$4.86K | 0.02% | 212 |
|
2019
Q1 | $480K | Buy |
+3,897
| New | +$480K | 0.02% | 211 |
|